Supernus Pharmaceuticals | SUPN - Trade Creditors


Supernus Pharmaceuticals reported $107.8M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Abbott USD 4.12B 183M Sep/2025
ANI Pharmaceuticals USD 62.58M 7.21M Dec/2025
Aurora Cannabis CAD 49.34M 31.94M Sep/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Canopy Growth CAD 18.14M 5.94M Sep/2025
Cara Therapeutics USD 2.42M 2.42M Jun/2025
Corcept Therapeutics USD 40.44M 6M Dec/2025
Eisai JPY 85.49B 4.76B Dec/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Novo Nordisk DKK 19.76B 4.15B Dec/2025
Pacira USD 15.15M 2.54M Dec/2025
Perrigo USD 474.5M 4.8M Dec/2025
Pfizer USD 5.02B 142M Sep/2025
Supernus Pharmaceuticals USD 107.8M 813K Dec/2025
United Therapeutics USD 7.1M 460.9M Dec/2025
Xeris Pharmaceuticals USD 6.53M 2.93M Sep/2025